FDA Delays Decision on Breast Cancer Drug Avastin

By: Associated Press
By: Associated Press

WASHINGTON (AP) - Drugmaker Roche says U.S. health regulators have delayed a decision on whether to expand approval of its drug Avastin for breast cancer, a use that has generated vigorous debate
among cancer specialists and patients.

The FDA granted Avastin accelerated approval for breast cancer in 2008 based on studies suggesting it halted the progression of the disease for more than five months. Roche submitted two additional studies last year designed to win full approval for the drug, although they did not confirm the results of its first study.

The FDA is now considering whether to revoke the drug's approval for breast cancer.

A panel of cancer experts supported that action in July, although cancer patients have petitioned the FDA to keep the drug available.

(Copyright 2010 by The Associated Press. All Rights Reserved.)

WTVY-TV 285 N Foster Street Dothan, AL 36303 334-792-3195
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 103172644 - wtvy.com/a?a=103172644
Gray Television, Inc.